drugset / Trial / NCT02323685
Safety and Effect of SANGUINATE™ Infusion in Patients at Risk of Delayed Cerebral Ischemia (DCI) Following Subarachnoid Hemorrhage (SAH)
NaSingle-groupOpen-label
Summary
Safety and effect of SANGUINATE on patients DCI following SAH.
Timeline
- Start
- 2014-12
- Primary completion
- 2016-06
- Completion
- 2016-10
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | pegylated carboxyhemoglobin bovine | Protein / enzyme biologic | — | — |